Cutaneous Vasculitis Associated with Zafirlukast Use in Asthma

Waleed Al‐Herz Divisions of Allergy and Clinical Immunology, Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, Delaware, 19803, USA; Thomas Jefferson University, Philadelphia, PennsylvaniaUSA

, M.D.,

Carlos Rosé Rheumatology, Nemours Children's Clinic, Wilmington, Alfred I. duPont Hospital for Children, Wilmington, DelawareUSA; Thomas Jefferson University, Philadelphia, PennsylvaniaUSA

, M.D. &

Stephen J. McGeady Divisions of Allergy and Clinical Immunology, Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, Delaware, 19803, USA; Thomas Jefferson University, Philadelphia, PennsylvaniaUSA

, M.D.

References

Wechsler M E, Finn D, Gunawardena D, Westlake R, Barker A, Haranath S P, Pauwels R A, Kips J C, Drazen J M. Churg‐Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000; 117(3)708–713
PubMed Web of Science ®Google Scholar
Knoell D L, Lucas J, Allen J N. Churg‐Strauss syndrome associated with zafirlukast. Chest 1998; 114(1)332–334
PubMed Web of Science ®Google Scholar
Kinoshita M, Shiraishi T, Koga T, Ayabe M, Rikimara T, Oizumi K. Churg‐Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol 1999; 103(3 Pt 1)534–535
PubMedGoogle Scholar
Weller P F, Plaut M, Taggart V, Trontell A. The relationship of asthma therapy and Churg‐Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 2001; 108(2)175–183
PubMedGoogle Scholar
Blanco R, Martinez‐Taboada V M, Rodriguez‐Valverde V, Garcia‐Fuentes M. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine 1998; 77(6)403–418
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Cutaneous Vasculitis Associated with Zafirlukast Use in Asthma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cutaneous Vasculitis Associated with Zafirlukast Use in Asthma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date